Zydus Wellness Limited (NSE: ZYDUSWELL)
India
· Delayed Price · Currency is INR | Market Cap | 121.61B |
| Revenue (ttm) | 25.20B |
| Net Income (ttm) | 3.19B |
| Shares Out | n/a |
| EPS (ttm) | 50.16 |
| PE Ratio | 38.10 |
| Forward PE | n/a |
| Dividend | 5.00 (0.25%) |
| Ex-Dividend Date | Jul 19, 2024 |
| Volume | 8,044 |
| Open | 1,882.00 |
| Previous Close | 1,897.40 |
| Day's Range | 1,882.00 - 1,913.00 |
| 52-Week Range | 1,440.15 - 2,484.00 |
| Beta | 0.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 14, 2025 |
About Zydus Wellness
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I’m lite a blended sugar coated with stevia. The company offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; pric... [Read more]
Financial Performance
In 2023, Zydus Wellness's revenue was 23.28 billion, an increase of 3.24% compared to the previous year's 22.55 billion. Earnings were 2.67 billion, a decrease of -14.01%.
Financial StatementsNews
Zydus Wellness shares in focus post Q2 results
Zydus Wellness Limited released its Q2 FY25 financial results, presenting a steady rise in revenue year-over-year but facing challenges in profitability on both a sequential and annual basis. This mix...
Zydus Wellness Q2 FY25 Results: Revenue up 12.1% YoY to Rs 492.9 crore, Net Profit jumps 254% to Rs 20.9 crore
Zydus Wellness Limited reported its financial results for the second quarter of FY25, showcasing steady performance in revenue with some challenges in profitability on a sequential and year-over-year ...